Azithromycin in the treatment of pneumonia caused by Chlamydia pneumoniae: Report of a case

J. H. Wang, J. H. Wang, Y. C. Liu, Y. S. Chen, M. Y. Yen, S. R. Wann, D. L. Cheng

研究成果: 雜誌貢獻文章

1 引文 斯高帕斯(Scopus)

摘要

We report a 67-year-old male with pneumoniae in which Chlamydia pneumoniae was identified by serologic studies as the causative agent. After initial treatment failure with amoxicillin + clavulanic acid, pneumonia was successfully treated with the administration or oral azithromycin, 500 mg per day, for three days. Azithromycin is a new macrolide which has a long half-life and superior action to erythromcyin. It provides a new and alternative choice in the treatment of Chlamydia pneumoniae infection in the future.

原文英語
頁(從 - 到)642-644
頁數3
期刊Journal of the Formosan Medical Association = Taiwan yi zhi
93
發行號7
出版狀態已發佈 - 1994
對外發佈Yes

    指紋

ASJC Scopus subject areas

  • Medicine(all)

引用此